Concepedia

Yoji Ikegami

YI

Statistics

Publications

22

Citations

2K

H-Index

17

Active since

1987

Affiliations

Meiji Pharmaceutical University(Current)

Tokyo Institute of Technology

Nagasaki University

Meiji (Japan)

Aichi Cancer Center

Yoji Ikegami is an author at Meiji Pharmaceutical University specializing in pharmacology, medicine, and molecular oncology.

Publications per year

1987–2016

22

Publications

22

Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.

K Tanabe, Yoji Ikegami, Ryoji Ishida et al. · PubMed · 1991 · 297 citations

, , +10

Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

T Andoh, Kazuyuki Ishii, Yoshio Suzuki et al. · Proceedings of the National Academy of Sciences · 1987 · 288 citations · Full text

, , +13

Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells

Shigeru Kawabata, Mikio Oka, Ken Shiozawa et al. · Biochemical and Biophysical Research Communications · 2001 · 239 citations

, , +12

Transport of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Breast Cancer Resistance Protein ABCG2 in Human Lung Cancer Cells

Katsumi Nakatomi, Megumi Yoshikawa, Mikio Oka et al. · Biochemical and Biophysical Research Communications · 2001 · 188 citations

, , +12

Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance

Yoichi Nakamura, Mikio Oka, Hiroshi Soda et al. · Cancer Research · 2005 · 177 citations · Full text

, , +15

1–5 of 22